CHATSWORTH, Calif., Nov. 11, 2009 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that it has appointed Lawrence J. Blecka, Ph.D., a senior executive with 30 years experience in medical device, diagnostics and biotechnology companies ranging from Fortune 500 to start-ups, as Vice President, Research and Development. Dr. Blecka will be responsible for overseeing all research and development of the Iris Diagnostics division, in support of the advancement of the Company’s existing and emerging product pipeline.
